Related references
Note: Only part of the references are listed.Antibodies to watch in 2020
Helene Kaplon et al.
MABS (2020)
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
Paola Toniati et al.
AUTOIMMUNITY REVIEWS (2020)
Will Complement Inhibition Be the New Target in Treating COVID-19-Related Systemic Thrombosis?
Courtney M. Campbell et al.
CIRCULATION (2020)
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
Shengyu Zhang et al.
CLINICAL DRUG INVESTIGATION (2020)
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
Mehmet Soy et al.
CLINICAL RHEUMATOLOGY (2020)
COVID-19 cytokine storm: The anger of inflammation
Mehdi Mahmudpour et al.
CYTOKINE (2020)
IL-6: Relevance for immunopathology of SARS-CoV-2
E. O. Gubernatorova et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Xiaobo Yang et al.
Lancet Respiratory Medicine (2020)
Complement activation in patients with COVID-19: A novel therapeutic target
Massimo Cugno et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis
Wenjie Tian et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis
Yinghao Cao et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
Cynthia Magro et al.
TRANSLATIONAL RESEARCH (2020)
The case of complement activation in COVID-19 multiorgan impact
Marina Noris et al.
KIDNEY INTERNATIONAL (2020)
Hyperinflammatory shock in children during COVID-19 pandemic
Shelley Riphagen et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
COVID-19 cytokine storm: the interplay between inflammation and coagulation
Ricardo J. Jose et al.
LANCET RESPIRATORY MEDICINE (2020)
The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
Sara Mastaglio et al.
CLINICAL IMMUNOLOGY (2020)
Emerging pharmacotherapies for COVID-19
Rachana Salvi et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Classical and lectin complement pathways and markers of inflammation for investigation of susceptibility to infections among healthy older adults
David C. LaFon et al.
IMMUNITY & AGEING (2020)
Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19
Ali Hassoun et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
Mark P. Lythgoe et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?
Natella Maglakelidze et al.
PULMONARY THERAPY (2020)
Complement as a target in COVID-19? (vol 20, pg 343, 2020)
Antonio M. Risitano et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the cytokine storm in COVID-19 patients: a hypothesis
Gregory Thomas et al.
PATIENT SAFETY IN SURGERY (2020)
Clinical promise of next-generation complement therapeutics
Dimitrios C. Mastellos et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Therapeutic targeting of the complement system
Daniel Ricklin et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV
Yuting Jiang et al.
EMERGING MICROBES & INFECTIONS (2018)
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
Lisa E. Gralinski et al.
MBIO (2018)
Complement: A primer for the coming therapeutic revolution
Scott R. Barnum
PHARMACOLOGY & THERAPEUTICS (2017)
Therapeutic Inhibition of Complement: Well Worth the Risk
Scott R. Barnum
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
The role of C5a in acute lung injury induced by highly pathogenic viral infections
Renxi Wang et al.
EMERGING MICROBES & INFECTIONS (2015)
The lectin pathway complement and rheumatic heart disease
Marcia Holsbach Beltrame et al.
FRONTIERS IN PEDIATRICS (2014)
Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection
HX Zhang et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection
WKE Ip et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Share Paper
